Segmentation by type classifies seaweed‑derived bio‑inks into four distinct families, each with sub‑categories that affect pricing, scalability, and end‑use performance. Alginate‑based inks dominate with variants such as low‑viscosity, high‑viscosity, and ion‑crosslinked formulations, prized for rapid gelation and cell‑friendly environments. Carrageenan‑based inks include kappa, iota, and lambda sub‑types, offering tunable mechanical strength and thermal stability for load‑bearing constructs. Agar‑based inks feature standard and modified agarose grades, favored in high‑resolution printing where thermal reversibility is critical. Composite inks blend seaweed polysaccharides with nanomaterials (e.g., silica nanoparticles, graphene oxide) or synthetic polymers to enhance conductivity, bioactivity, or print fidelity. The proportional market contribution aligns with application demand: alginate inks capture ~40 %, carrageenan ~25 %, agar ~20 %, and composites ~15 %, reflecting the premium placed on functional enhancements in advanced biomedical and industrial use‑cases.